Keyphrases
5-fluorouracil (5-FU)
23%
Adenocarcinoma
10%
Adenoma
9%
Allelic Loss
9%
Cancer Families
10%
Carcinoma
27%
CDH1
12%
CDH1 mutation
12%
Cetuximab
11%
Chemotherapy
15%
Chromosomal Instability
9%
Cisplatin
15%
Colorectal Cancer
20%
Cyclin D1 (CCND1)
11%
Diffuse-type Gastric Cancer
13%
E-cadherin
32%
E-cadherin Gene
10%
E-cadherin mutations
13%
Epidermal Growth Factor Receptor
13%
Esophageal Adenocarcinoma
10%
Gastric Cancer
100%
Gastric Cancer Patients
16%
Gastric Carcinoma
35%
Gene Expression
9%
Genotype
11%
Germ Cells
16%
Germline mutation
25%
Hereditary Colorectal Cancer Syndromes
40%
Hereditary Diffuse Gastric Cancer
16%
Immunohistochemistry
10%
Loss of Heterozygosity
36%
Microsatellite Instability-high (MSI-H)
85%
Microsatellites
11%
MLH1
20%
MSH2
15%
MSH6
9%
Mutation Carriers
16%
Neoadjuvant
27%
Neoadjuvant Chemotherapy
20%
Neoadjuvant Therapy
9%
Non-associated
12%
Overall Survival
14%
Polymorphism
22%
Prognostic Impact
13%
Remnant Gastric Cancer
13%
Response Prediction
10%
Response to Neoadjuvant Chemotherapy
9%
TP53 mutation
12%
Tumor
69%
Upper Gastrointestinal Tract
18%
Biochemistry, Genetics and Molecular Biology
Allelic Imbalance
6%
Cadherin
32%
Cancer Cell
6%
Carcinogenesis
9%
Cell Adhesion Proteins
6%
Chromosome Instability
8%
Cisplatin
20%
Colon
15%
Cyclin D1
8%
DNA Mismatch Repair
16%
DNA Repair
8%
Drug Resistance
6%
Epidermal Growth Factor Receptor
11%
Epimutation
5%
Epstein Barr Virus
5%
Esophagus
11%
Exon
12%
Fluorouracil
16%
Gene Expression
11%
Gene Mutation
10%
Genetic Heterogeneity
6%
Genetic Predisposition
7%
Genetics
23%
Genomics
12%
Genotyping
12%
Germ Cell
15%
Germline
15%
Germline Mutation
29%
KRAS
11%
Loss of Heterozygosity
36%
Messenger RNA
7%
Methylation
12%
Microsatellite
35%
Microsatellite Instability
63%
Missense Mutation
5%
MLH1
24%
MSH2
19%
MSH6
8%
Mutation Rate
5%
MUTYH
5%
Oncogene
7%
Overall Survival
22%
Oxidoreductase
5%
P53
17%
Promoter Region
16%
Protein P53
5%
Real-Time Polymerase Chain Reaction
6%
Thymidylate Synthase
7%
Tumor Suppressor Gene
7%
Upper Digestive Tract
17%
Medicine and Dentistry
Abdominal Cancer
61%
Adenocarcinoma
15%
Adenoma
11%
Biological Marker
10%
Biopsy Technique
6%
Breast Carcinoma
5%
Cancer
7%
Carcinoma
20%
Chromosomal Instability
6%
Cisplatin
8%
Colon Carcinoma
8%
Colorectal Carcinoma
19%
Cyclin D1
5%
Diseases
10%
DNA Mismatch Repair
10%
Esophageal Adenocarcinoma
6%
Exon
7%
Formaldehyde
5%
Gastrectomy
7%
Gene Expression
8%
Germ Cell
5%
Germline Mutation
20%
Hazard Ratio
5%
HDAC1
5%
Hereditary Colorectal Cancer
5%
Hereditary Diffuse Gastric Cancer
8%
Hereditary Nonpolyposis Colorectal Cancer
22%
Heterozygosity
13%
Histone Deacetylase 2
5%
Immunohistochemistry
7%
Malignant Neoplasm
13%
Medicine
5%
Methylation
6%
Microsatellite Instability
27%
Molecular Pathology
5%
Neoadjuvant Chemotherapy
16%
Neoplasm
57%
Neuroendocrine Carcinoma
6%
Overall Survival
12%
Oxidoreductase
5%
Prognostic Factor
10%
Protein P53
15%
Rectum Cancer
5%
Recurrent Disease
5%
Stomach Adenocarcinoma
9%
Stomach Carcinoma
19%
Surgery
6%
Tumor Regression
5%
Upper Digestive Tract
7%
Uvomorulin
15%
